EB-203

N/A

Report date: 2024/09/04 14:26:06

NME

Base Information

Drug NameEB-203

Drug Alias NameEB-203

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAngiogenesis inhibitors

TargetsUpdating

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesEyebioKorea Inc

China Registration ClassN/A

Active CompaniesEyebioKorea Inc

Inactive CompaniesN/A

Active IndicationsMacular Degeneration

Inactive IndicationsN/A

ATC CodeN/A